1. Home
  2. ZCMD vs NVNO Comparison

ZCMD vs NVNO Comparison

Compare ZCMD & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

HOLD

Current Price

$1.70

Market Cap

6.1M

Sector

Real Estate

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$10.31

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZCMD
NVNO
Founded
2012
1987
Country
China
United States
Employees
N/A
37
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ZCMD
NVNO
Price
$1.70
$10.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.4M
11.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.30
52 Week High
$1.87
$12.79

Technical Indicators

Market Signals
Indicator
ZCMD
NVNO
Relative Strength Index (RSI) 83.56 57.82
Support Level $1.02 $0.49
Resistance Level N/A $12.64
Average True Range (ATR) 0.09 1.08
MACD 0.16 -0.28
Stochastic Oscillator 86.83 40.70

Price Performance

Historical Comparison
ZCMD
NVNO

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: